Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Binocular Inhibition of Reading in Macular Telangiectasia Type 2.

Tzaridis S, Herrmann P, Charbel Issa P, Degli Esposti S, Wagner SK, Fruttiger M, Egan C, Rubin G, Holz FG, Heeren TFC.

Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3835-3841. doi: 10.1167/iovs.18-26414.

PMID:
31529080
2.

Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.

Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander M.

N Engl J Med. 2019 Oct 10;381(15):1422-1433. doi: 10.1056/NEJMoa1815111. Epub 2019 Sep 11.

PMID:
31509666
3.

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System.

Okada M, Heeren TFC, Mulholland PJ, Maloca PM, Cilkova M, Rocco V, Fruttiger M, Egan CA, Anderson RS, Tufail A.

Transl Vis Sci Technol. 2019 Jun 27;8(3):54. doi: 10.1167/tvst.8.3.54. eCollection 2019 May.

4.

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.

Heeren TFC, Tzaridis S, Bonelli R, Pfau M, Fruttiger M, Okada M, Egan C, Charbel Issa P, Holz FG.

Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1760-1767. doi: 10.1167/iovs.18-25360.

PMID:
31022297
5.

p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia.

Yokoyama M, Shimizu I, Nagasawa A, Yoshida Y, Katsuumi G, Wakasugi T, Hayashi Y, Ikegami R, Suda M, Ota Y, Okada S, Fruttiger M, Kobayashi Y, Tsuchida M, Kubota Y, Minamino T.

J Mol Cell Cardiol. 2019 Apr;129:105-117. doi: 10.1016/j.yjmcc.2019.02.010. Epub 2019 Feb 18.

PMID:
30790589
6.

Inhibition of stromal cell-derived factor-1α/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas.

Omori K, Nagata N, Kurata K, Fukushima Y, Sekihachi E, Fujii N, Namba-Hamano T, Takabatake Y, Fruttiger M, Nagasawa T, Uemura A, Murata T.

JCI Insight. 2018 Dec 6;3(23). pii: 120706. doi: 10.1172/jci.insight.120706.

7.

Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.

Müller S, Heeren TFC, Bonelli R, Fruttiger M, Charbel Issa P, Egan CA, Holz FG.

Br J Ophthalmol. 2019 Mar;103(3):398-403. doi: 10.1136/bjophthalmol-2017-311785. Epub 2018 Jun 1.

PMID:
29858186
8.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

9.

Retinal vasculature development in health and disease.

Selvam S, Kumar T, Fruttiger M.

Prog Retin Eye Res. 2018 Mar;63:1-19. doi: 10.1016/j.preteyeres.2017.11.001. Epub 2017 Nov 10. Review.

PMID:
29129724
10.

FUNDUS-WIDE SUBRETINAL AND PIGMENT EPITHELIAL ABNORMALITIES IN MACULAR TELANGIECTASIA TYPE 2.

Powner MB, Woods SM, Zhu M, Gillies MC, Bernstein PS, Hageman GS, Comer GM, Egan C, Fruttiger M.

Retina. 2018 Jan;38 Suppl 1:S105-S113. doi: 10.1097/IAE.0000000000001860.

PMID:
29045321
11.

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.

Sakabe M, Fan J, Odaka Y, Liu N, Hassan A, Duan X, Stump P, Byerly L, Donaldson M, Hao J, Fruttiger M, Lu QR, Zheng Y, Lang RA, Xin M.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10918-10923. doi: 10.1073/pnas.1704030114. Epub 2017 Sep 25.

12.

Conditional Müller Cell Ablation Leads to Retinal Iron Accumulation.

Baumann B, Sterling J, Song Y, Song D, Fruttiger M, Gillies M, Shen W, Dunaief JL.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4223-4234. doi: 10.1167/iovs.17-21743.

13.

MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease.

Okada M, Egan CA, Heeren TFC, Tufail A, Fruttiger M, Maloca PM.

Retina. 2018 Jan;38 Suppl 1:S97-S104. doi: 10.1097/IAE.0000000000001812.

PMID:
28834952
14.

ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE-FUNCTION CORRELATION.

Okada M, Robson AG, Egan CA, Sallo FB, Esposti SD, Heeren TFC, Fruttiger M, Holder GE.

Retina. 2018 Jan;38 Suppl 1:S33-S42. doi: 10.1097/IAE.0000000000001746.

PMID:
28654458
15.

EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2.

Okada M, Heeren TFC, Egan CA, Rocco V, Bonelli R, Fruttiger M.

Retina. 2018 Jan;38 Suppl 1:S89-S96. doi: 10.1097/IAE.0000000000001754.

PMID:
28654457
16.

ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, Pauleikhoff D, Chew EY, Egan C, Peto T, Bird AC; MacTel Study Group.

Retina. 2018 Jan;38 Suppl 1:S79-S88. doi: 10.1097/IAE.0000000000001728.

17.

Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.

Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, Ivanov A, Szymborska A, Patone G, Kunz S, Sommermeyer D, Engels B, Leisegang M, Textor A, Fehling HJ, Fruttiger M, Lohoff M, Herrmann A, Yu H, Weichselbaum R, Uckert W, Hübner N, Gerhardt H, Beule D, Schreiber H, Blankenstein T.

Nature. 2017 May 4;545(7652):98-102. doi: 10.1038/nature22311. Epub 2017 Apr 26.

18.

Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, Scheppke L, Bonelli R, Yannuzzi LA, Friedlander M; MacTel Project Consortium, Egan CA, Fruttiger M, Leppert M, Allikmets R, Bahlo M.

Nat Genet. 2017 Apr;49(4):559-567. doi: 10.1038/ng.3799. Epub 2017 Feb 27.

PMID:
28250457
19.

Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation.

Fernández-Robredo P, Selvam S, Powner MB, Sim DA, Fruttiger M.

PLoS One. 2017 Jan 20;12(1):e0169865. doi: 10.1371/journal.pone.0169865. eCollection 2017.

20.

Endothelial FAK is required for tumour angiogenesis.

Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M, Hodivala-Dilke KM.

EMBO Mol Med. 2016 Oct 4;8(10):1229. doi: 10.15252/emmm.201606907. Print 2016 Oct. No abstract available.

21.

Evaluation of Nonperfused Retinal Vessels in Ischemic Retinopathy.

Powner MB, Sim DA, Zhu M, Nobre-Cardoso J, Jones R, Syed A, Chang AA, Keane PA, Tufail A, Egan CA, Fruttiger M.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):5031-5037. doi: 10.1167/iovs.16-20007.

PMID:
27661854
22.

Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways.

Wu J, Su W, Powner MB, Liu J, Copland DA, Fruttiger M, Madeddu P, Dick AD, Liu L.

Sci Rep. 2016 Aug 25;6:31873. doi: 10.1038/srep31873.

23.

Diverse Functions of Retinoic Acid in Brain Vascular Development.

Bonney S, Harrison-Uy S, Mishra S, MacPherson AM, Choe Y, Li D, Jaminet SC, Fruttiger M, Pleasure SJ, Siegenthaler JA.

J Neurosci. 2016 Jul 20;36(29):7786-801. doi: 10.1523/JNEUROSCI.3952-15.2016.

24.

Corrigendum: Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.

Joyal JS, Sun Y, Gantner ML, Shao Z, Evans LP, Saba N, Fredrick T, Burnim S, Kim JS, Patel G, Juan AM, Hurst CG, Hatton CJ, Cui Z, Pierce KA, Bherer P, Aguilar E, Powner MB, Vevis K, Boisvert M, Fu Z, Levy E, Fruttiger M, Packard A, Rezende FA, Maranda B, Sapieha P, Chen J, Friedlander M, Clish CB, Smith LE.

Nat Med. 2016 Jun 7;22(6):692. doi: 10.1038/nm0616-692a. No abstract available.

PMID:
27270778
25.

Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.

Joyal JS, Sun Y, Gantner ML, Shao Z, Evans LP, Saba N, Fredrick T, Burnim S, Kim JS, Patel G, Juan AM, Hurst CG, Hatton CJ, Cui Z, Pierce KA, Bherer P, Aguilar E, Powner MB, Vevis K, Boisvert M, Fu Z, Levy E, Fruttiger M, Packard A, Rezende FA, Maranda B, Sapieha P, Chen J, Friedlander M, Clish CB, Smith LE.

Nat Med. 2016 Apr;22(4):439-45. doi: 10.1038/nm.4059. Epub 2016 Mar 14. Erratum in: Nat Med. 2016 Jun 7;22(6):692.

26.

FOXO1 couples metabolic activity and growth state in the vascular endothelium.

Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, Zimmermann B, Aspalter IM, Franco CA, Boettger T, Braun T, Fruttiger M, Rajewsky K, Keller C, Brüning JC, Gerhardt H, Carmeliet P, Potente M.

Nature. 2016 Jan 14;529(7585):216-20. doi: 10.1038/nature16498. Epub 2016 Jan 6.

27.

A simple method for in vivo labelling of infiltrating leukocytes in the mouse retina using indocyanine green dye.

Sim DA, Chu CJ, Selvam S, Powner MB, Liyanage S, Copland DA, Keane PA, Tufail A, Egan CA, Bainbridge JW, Lee RW, Dick AD, Fruttiger M.

Dis Model Mech. 2015 Nov;8(11):1479-87. doi: 10.1242/dmm.019018. Epub 2015 Aug 20.

28.

PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.

Serra H, Chivite I, Angulo-Urarte A, Soler A, Sutherland JD, Arruabarrena-Aristorena A, Ragab A, Lim R, Malumbres M, Fruttiger M, Potente M, Serrano M, Fabra À, Viñals F, Casanovas O, Pandolfi PP, Bigas A, Carracedo A, Gerhardt H, Graupera M.

Nat Commun. 2015 Jul 31;6:7935. doi: 10.1038/ncomms8935.

29.

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice.

Jo DH, Park SW, Cho CS, Powner MB, Kim JH, Fruttiger M, Kim JH.

PLoS One. 2015 Jul 30;10(7):e0134308. doi: 10.1371/journal.pone.0134308. eCollection 2015.

30.

Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch.

Aspalter IM, Gordon E, Dubrac A, Ragab A, Narloch J, Vizán P, Geudens I, Collins RT, Franco CA, Abrahams CL, Thurston G, Fruttiger M, Rosewell I, Eichmann A, Gerhardt H.

Nat Commun. 2015 Jun 17;6:7264. doi: 10.1038/ncomms8264.

31.

cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels.

Stanczuk L, Martinez-Corral I, Ulvmar MH, Zhang Y, Laviña B, Fruttiger M, Adams RH, Saur D, Betsholtz C, Ortega S, Alitalo K, Graupera M, Mäkinen T.

Cell Rep. 2015 Mar 17;10(10):1708-1721. doi: 10.1016/j.celrep.2015.02.026. Epub 2015 Mar 12.

32.

Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes.

Liew G, Sim DA, Keane PA, Tan AG, Mitchell P, Wang JJ, Wong TY, Fruttiger M, Tufail A, Egan CA.

Acta Ophthalmol. 2015 Feb;93(1):e45-51. doi: 10.1111/aos.12519.

33.

Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.

Song HB, Jun HO, Kim JH, Fruttiger M, Kim JH.

Cell Calcium. 2015 Feb;57(2):101-8. doi: 10.1016/j.ceca.2015.01.002. Epub 2015 Jan 10.

PMID:
25605522
34.

Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography.

Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M, Egan CA, Tufail A.

Am J Ophthalmol. 2015 Jan;159(1):101-10.e1. doi: 10.1016/j.ajo.2014.09.041. Epub 2014 Oct 25.

35.

The ubiquitin ligase PDZRN3 is required for vascular morphogenesis through Wnt/planar cell polarity signalling.

Sewduth RN, Jaspard-Vinassa B, Peghaire C, Guillabert A, Franzl N, Larrieu-Lahargue F, Moreau C, Fruttiger M, Dufourcq P, Couffinhal T, Duplàa C.

Nat Commun. 2014 Sep 8;5:4832. doi: 10.1038/ncomms5832.

PMID:
25198863
36.

A crucial role for CDC42 in senescence-associated inflammation and atherosclerosis.

Ito TK, Yokoyama M, Yoshida Y, Nojima A, Kassai H, Oishi K, Okada S, Kinoshita D, Kobayashi Y, Fruttiger M, Aiba A, Minamino T.

PLoS One. 2014 Jul 24;9(7):e102186. doi: 10.1371/journal.pone.0102186. eCollection 2014.

37.

Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression.

Tual-Chalot S, Mahmoud M, Allinson KR, Redgrave RE, Zhai Z, Oh SP, Fruttiger M, Arthur HM.

PLoS One. 2014 Jun 4;9(6):e98646. doi: 10.1371/journal.pone.0098646. eCollection 2014.

38.

Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity.

Yokoyama M, Okada S, Nakagomi A, Moriya J, Shimizu I, Nojima A, Yoshida Y, Ichimiya H, Kamimura N, Kobayashi Y, Ohta S, Fruttiger M, Lozano G, Minamino T.

Cell Rep. 2014 Jun 12;7(5):1691-1703. doi: 10.1016/j.celrep.2014.04.046. Epub 2014 May 22.

39.

Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography.

Sim DA, Keane PA, Rajendram R, Karampelas M, Selvam S, Powner MB, Fruttiger M, Tufail A, Egan CA.

Am J Ophthalmol. 2014 Jul;158(1):144-153.e1. doi: 10.1016/j.ajo.2014.03.009. Epub 2014 Apr 4.

PMID:
24709807
40.

Expression of neonatal Fc receptor in the eye.

Powner MB, McKenzie JA, Christianson GJ, Roopenian DC, Fruttiger M.

Invest Ophthalmol Vis Sci. 2014 Mar 19;55(3):1607-15. doi: 10.1167/iovs.13-12574.

41.

Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).

Scott A, Powner MB, Fruttiger M.

Exp Eye Res. 2014 Mar;120:55-60. doi: 10.1016/j.exer.2013.12.020. Epub 2014 Jan 10.

PMID:
24418725
42.

Quantitative analysis of diabetic macular ischemia using optical coherence tomography.

Sim DA, Keane PA, Fung S, Karampelas M, Sadda SR, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Invest Ophthalmol Vis Sci. 2014 Jan 21;55(1):417-23. doi: 10.1167/iovs.13-12677.

PMID:
24398090
43.

Crim1 maintains retinal vascular stability during development by regulating endothelial cell Vegfa autocrine signaling.

Fan J, Ponferrada VG, Sato T, Vemaraju S, Fruttiger M, Gerhardt H, Ferrara N, Lang RA.

Development. 2014 Jan;141(2):448-59. doi: 10.1242/dev.097949. Epub 2013 Dec 18.

44.

Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation.

Aboualaiwi WA, Muntean BS, Ratnam S, Joe B, Liu L, Booth RL, Rodriguez I, Herbert BS, Bacallao RL, Fruttiger M, Mak TW, Zhou J, Nauli SM.

Circulation. 2014 Feb 11;129(6):660-72. doi: 10.1161/CIRCULATIONAHA.113.005746. Epub 2013 Nov 14.

45.

Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.

Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, Edwards D, Fruttiger M, Hodivala-Dilke KM, Robinson SD.

Circ Res. 2014 Jan 3;114(1):79-91. doi: 10.1161/CIRCRESAHA.114.301591. Epub 2013 Oct 8.

PMID:
24103390
46.

Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury.

Ham A, Kim M, Kim JY, Brown KM, Fruttiger M, D'Agati VD, Lee HT.

Kidney Int. 2014 Apr;85(4):807-23. doi: 10.1038/ki.2013.345. Epub 2013 Sep 11.

47.

Whole mount immunofluorescent staining of the neonatal mouse retina to investigate angiogenesis in vivo.

Tual-Chalot S, Allinson KR, Fruttiger M, Arthur HM.

J Vis Exp. 2013 Jul 9;(77):e50546. doi: 10.3791/50546.

48.

Predictive factors for the progression of diabetic macular ischemia.

Sim DA, Keane PA, Zarranz-Ventura J, Bunce CV, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Am J Ophthalmol. 2013 Oct;156(4):684-92. doi: 10.1016/j.ajo.2013.05.033. Epub 2013 Jul 24.

PMID:
23891332
49.

Keeping blood vessels out of sight.

Sim D, Fruttiger M.

Elife. 2013 Jun 18;2:e00948. doi: 10.7554/eLife.00948.

50.

Loss of Müller's cells and photoreceptors in macular telangiectasia type 2.

Powner MB, Gillies MC, Zhu M, Vevis K, Hunyor AP, Fruttiger M.

Ophthalmology. 2013 Nov;120(11):2344-52. doi: 10.1016/j.ophtha.2013.04.013. Epub 2013 Jun 12.

PMID:
23769334

Supplemental Content

Loading ...
Support Center